Lipella Pharmaceuticals LIPO
LIPO
$0.00 +0.00 (+0.00%)
At close: Oct 19, 2026 · 4:00 PM EDT

Lipella Pharmaceuticals Inc. (LIPO) Operating Income (2022 - 2025)

Updated

Lipella Pharmaceuticals' Operating Income came in at -$1.27 million for Q3 2025, compared with -$1.46 million a year earlier.

Analysis

Lipella Pharmaceuticals Inc. (LIPO) Operating Income (2022 - 2025) Analysis & Trends

Over the trailing twelve months to Sep 30, 2025, Lipella Pharmaceuticals reported Operating Income of -$5.41 million; for FY2024, it was -$5.08 million.

  • Going back by year, Operating Income was -$4.75 million in FY2023, -$2.59 million in FY2022 and -$1.92 million in FY2021.
  • The Q3 2025 figure represents the highest quarterly Operating Income since Q2 2024.
  • Business Quant data shows LIPO's Operating Income at -$1.36 million (Q2 2025), -$1.33 million (Q1 2025) and -$1.45 million (Q4 2024) in the three quarters before Q3 2025.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -1.27 Mn
Jun 30, 2025 -1.36 Mn
Mar 31, 2025 -1.33 Mn
Dec 31, 2024 -1.45 Mn
Sep 30, 2024 -1.46 Mn
Jun 30, 2024 -952,189.00
Mar 31, 2024 -1.22 Mn
Dec 31, 2023 -729,594.00
Sep 30, 2023 -1.36 Mn
Jun 30, 2023 -1.58 Mn
Mar 31, 2023 -1.08 Mn
Dec 31, 2022 -359,263.00
Sep 30, 2022 -712,642.00
Jun 30, 2022 -781,147.00
Mar 31, 2022 -736,663.00
API Access

Lipella Pharmaceuticals Inc. Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=LIPO&period=max&api_key=YOUR_API_KEY